• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

m-Hydroxyphenylacetic acid formation from L-dopa in man: suppression by neomycin.

作者信息

Sandler M, Karoum F, Ruthven C R, Calne D B

出版信息

Science. 1969 Dec 12;166(3911):1417-8. doi: 10.1126/science.166.3911.1417.

DOI:10.1126/science.166.3911.1417
PMID:5350345
Abstract

The increased excretion of m-hydroxyphenylacetic acid in the urine of patients with parkinsonism being treated with L-dopa was reduced by gut sterilization with neomycin. The p-de-hydroxylation step is thus brought about solely by the action of gut flora; the pathway is unlikely to be involved in the events within the brain leading to the therapeutic benefit effected by L-dopa.

摘要

相似文献

1
m-Hydroxyphenylacetic acid formation from L-dopa in man: suppression by neomycin.
Science. 1969 Dec 12;166(3911):1417-8. doi: 10.1126/science.166.3911.1417.
2
The metabolism of orally administered L-Dopa in Parkinsonism.帕金森病中口服左旋多巴的代谢
Br J Pharmacol. 1969 Sep;37(1):57-68. doi: 10.1111/j.1476-5381.1969.tb09522.x.
3
The excretion of L-dopa metabolites at different hours of the day.
Curr Ther Res Clin Exp. 1972 Nov;14(11):749-57.
4
Metabolism of dopa in Parkinsonism.帕金森病中多巴的代谢
N Engl J Med. 1969 Dec 18;281(25):1429.
5
A simple and rapid gas chromatography for determining 3,4-dihydroxyphenylacetic acid and 3-methoxy-4-hydroxyphenylacetic acid in urine from patients with parkinsonism treated with L-3,4-dihydroxyphenylalanine.
Clin Chim Acta. 1971 Jul;33(2):470-2. doi: 10.1016/0009-8981(71)90512-2.
6
EEG and urinary non-catecholic amine changes during L-dopa therapy of Parkinson's disease.帕金森病左旋多巴治疗期间脑电图及尿中非儿茶酚胺的变化
Dis Nerv Syst. 1972 Mar;33(3):164-9.
7
Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy.接受左旋多巴治疗的帕金森病患者尿液中左旋多巴及其代谢产物的排泄情况。
Clin Chem. 1971 Sep;17(9):867-71.
8
Gut flora and the origin of some urinary aromatic phenolic compounds.肠道菌群与某些尿液芳香酚类化合物的来源
Biochem Pharmacol. 1994 Jun 15;47(12):2294-7. doi: 10.1016/0006-2952(94)90268-2.
9
Excretion of dopa metabolites.多巴代谢物的排泄。
N Engl J Med. 1971 Feb 18;284(7):395. doi: 10.1056/nejm197102182840725.
10
Studies on the metabolism and excretion of L-3,4-dihydroxyphenylalanine (L-DOPA) in human beings by gas chromatography.采用气相色谱法对人体中L-3,4-二羟基苯丙氨酸(L-DOPA)的代谢和排泄进行的研究。
Chem Pharm Bull (Tokyo). 1972 Apr;20(4):759-64. doi: 10.1248/cpb.20.759.

引用本文的文献

1
Urinary based biomarkers identification and genetic profiling in Parkinson's disease: a systematic review of metabolomic studies.帕金森病中基于尿液的生物标志物识别与基因谱分析:代谢组学研究的系统综述
Front Bioinform. 2025 Mar 10;5:1513790. doi: 10.3389/fbinf.2025.1513790. eCollection 2025.
2
Enantiocomplementary Gut Bacterial Enzymes Metabolize Dietary Polyphenols.对映体互补性肠道细菌酶代谢膳食多酚。
J Am Chem Soc. 2025 Mar 5;147(9):7231-7244. doi: 10.1021/jacs.4c09892. Epub 2025 Feb 24.
3
Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson's disease.
药物微生物组学:一个有助于优化帕金森病药物治疗的新领域。
Gut Microbes. 2025 Dec;17(1):2454937. doi: 10.1080/19490976.2025.2454937. Epub 2025 Jan 28.
4
Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities.微生物代谢的奇迹:微生物药物转化能力的综合评述。
Gut Microbes. 2024 Jan-Dec;16(1):2387400. doi: 10.1080/19490976.2024.2387400. Epub 2024 Aug 16.
5
Gut instincts in neuroimmunity from the eighteenth to twenty-first centuries.从 18 世纪到 21 世纪的神经免疫中的本能直觉。
Semin Immunopathol. 2022 Sep;44(5):569-579. doi: 10.1007/s00281-022-00948-2. Epub 2022 Jul 4.
6
Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.全面的尿液代谢组学分析及特发性帕金森病潜在无创标志物的鉴定。
Sci Rep. 2015 Sep 14;5:13888. doi: 10.1038/srep13888.
7
Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids.综述:肠道微生物群改变药物和胆汁酸作用的机制
Drug Metab Dispos. 2015 Oct;43(10):1505-21. doi: 10.1124/dmd.115.065698. Epub 2015 Aug 10.
8
Determination of regional distributions of phenylethylamine and meta- and para-tyramine in rat brain regions and presence in human and dog plasma by an ultra-sensitive negative chemical ion gas chromatography-mass spectrometric (NCI-GC-MS) method.采用超灵敏负化学离子气相色谱 - 质谱联用(NCI - GC - MS)法测定大鼠脑区中苯乙胺、间酪胺和对酪胺的区域分布以及人和犬血浆中的含量。
Neurochem Res. 1993 Sep;18(9):995-1002. doi: 10.1007/BF00966759.
9
Drug metabolism by the gastrointestinal mucosa.胃肠道黏膜的药物代谢
Clin Pharmacokinet. 1981 Jul-Aug;6(4):259-74. doi: 10.2165/00003088-198106040-00002.
10
Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.左旋多巴:对其药理特性及治疗用途的综述,特别提及帕金森病
Drugs. 1971;2(4):262-400. doi: 10.2165/00003495-197102040-00002.